CNBC's Andrea Day goes inside a Ponzi scheme run by one man, who singlehandedly conned hundreds of investors out of $230 million.» Read More
CNBC's Bob Pisani reports on the decline in Dubai's main stock market.
Discussing the outlook for equities and inflation, with Kevin Mahn, Hennion & Walsh Asset Management, and Mark Travis, Intrepid Capital Funds.
Sales of newly built homes were up 18.6 percent month-to-month in May, reports CNBC's Diana Olick. New home sales are 64 percent below their peak in 2005.
CNBC's Bertha Coombs provides insight to a PwC study which shows employer medical costs rising in 2015 for the first time in 5 years.
CNBC's Meg Tirrell explains how cystic fibrosis occurs in the body, and the breakthrough announcement from Vertex Pharmaceuticals.
Discussing the possibility of success for Vertex Pharmaceuticals' cystic fibrosis drugs, and what it means for the stock, with Matt Roden, UBS executive director.
Here are a couple of things that could interfere with the bull run to Dow 17,000, says NYSE floor trader Kenny Polcari.
Of the 30 stocks on the Dow, only seven have not hit 52-week highs this year. Is it time to bet on these underperformers?
Where is the top state for business in America? CNBC's Scott Cohn explains the methodology behind CNBC's study.
What's dragging down the consumer discretionary sector this year, with CNBC's Seema Mody.
Todd Rosenbluth, S&P Capital IQ, shares his top stock picks in the consumer discretionary space.
CNBC's Sue Herera, Simon Hobbs and Julia Boorstin, look at today's "Power Lunch" stories, including a study on "rich people problems."
Discussing the play on Verizon, Nike and other big cap stocks, as well as how to play IBM at its current low level, with Jim Iuorio, TJM Institutional Services, and Jeff Kilburg, KKM Financial.
If the Dow goes above 17,000, will energy continue to lead? Abigail Doolittle, Peak Theories, and Todd Rosenbluth, S&P Capital IQ, share their energy forecasts.
CNBC's Meg Tirrell reports on everything investors need to know about Vertex Pharmaceuticals' upcoming data release on a combination of drugs for cystic fibrosis.
CNBC's Bob Pisani says the IPO market will follow equities. Pisani provides insight to the "tsunami of IPOs" on its way.
CNBC's Diana Olick reports home sales took a larger than expected bump up in May.
Discussing oil's next move amid crisis in Iraq, with Peter Amandio, Chicago Energies President.
More Iraqi cities have fallen to the heavily armed al-Qaida linked Sunni group. CNBC's Michelle Caruso-Cabrera has the details.
How to play underperforming large cap stocks, with Kristina Hooper, Allianz Global Investors, and Noah Blackstein, Dynamic Funds.
Skillz CEO Andrew Paradise pitches his competition gaming platform. Will the "Power Pitch" panel say game on—or game over?
Watch iFunding CEO William Skelley pitch his big idea to a panel of experts in just 60 seconds.
Man Crates CEO and founder Jonathan Beekman gives his 60-second pitch to a panel of experts.
Did the Fed just hint at tapering in December? Kenny Polcari parses the Fed speak — and parses some pasta scraps for a good recipe!
In this issue of "What's cookin' with Kenny Polcari," Kenny whips up a few Fed tidbits and something to dazzle your Thanksgiving guests.
Pro trader Kenny Polcari shares his thoughts on where the market is headed, as well as his recipe of the day.